Interestingly, SLC22A5 has been recently reported to be critical for the survival of glioma cells [31,32], supporting increased fatty acid metabolism, which is possibly mirrored in our positive correlation with [18F]FPIA uptake. The gene discussed is SLC22A5; the disease is central nervous system cancer.